Treatment of Occluded Infected Gallbladder
The standard treatment for an occluded infected gallbladder is early laparoscopic cholecystectomy within 7-10 days of symptom onset, combined with appropriate antibiotic therapy. 1
Diagnosis
- First-line imaging: Ultrasonography (sensitivity ~81%, specificity ~83%)
- Key findings: gallstones, gallbladder wall thickening, pericholecystic fluid, distended gallbladder, positive sonographic Murphy's sign 1
- Alternative imaging: CT with IV contrast if ultrasound is inconclusive 1
- Clinical signs: Right upper quadrant pain, Murphy's sign, fever, abdominal tenderness 2
Treatment Algorithm
1. Surgical Management
Primary treatment: Early laparoscopic cholecystectomy within 7-10 days of symptom onset 2, 1
Alternative for high-risk patients: Percutaneous cholecystostomy
2. Antibiotic Therapy
For non-critically ill, immunocompetent patients:
- First-line: Amoxicillin/Clavulanate 2g/0.2g q8h 2
- If beta-lactam allergy:
- Eravacycline 1 mg/kg q12h OR
- Tigecycline 100 mg loading dose, then 50 mg q12h 2
- Duration: 4 days if source control is adequate 2
For critically ill or immunocompromised patients:
- First-line: Piperacillin/tazobactam 6g/0.75g loading dose then 4g/0.5g q6h or 16g/2g by continuous infusion 2, 1
- Duration: Up to 7 days based on clinical condition and inflammatory markers 2
Important Considerations
- Timing is critical: Delaying surgery beyond 72 hours increases complication rates 1
- Antibiotic duration: Patients with ongoing signs of infection beyond 7 days warrant further diagnostic investigation 2
- Monitoring: Daily assessment of clinical response and renal function, especially in elderly patients 1
- Fluid management: Goal-directed fluid therapy for resuscitation 1
Potential Complications
- Bile duct injuries (serious complication of laparoscopic cholecystectomy) 1
- Gangrenous cholecystitis, emphysematous cholecystitis, gallbladder perforation, and hemorrhagic cholecystitis 1
- Higher mortality rates in acalculous cholecystitis (45.2%) compared to calculous cholecystitis (21.2%) 1
Cautions
- Elderly patients may require antibiotic dose adjustments due to altered pharmacokinetics 1
- Patients with renal/hepatic dysfunction require careful monitoring and potential dose adjustments 1
- Unnecessary prolonged antibiotic therapy increases the risk of resistance 1
- Aminoglycosides should be used cautiously in elderly patients with biliary infections due to potential nephrotoxicity 3